News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVasc Therapeutics Adds Two Leaders to Scientific Advisory Board


4/5/2012 11:23:49 AM

ATLANTA--(BUSINESS WIRE)--InVasc Therapeutics, Inc., a leading developer of drugs for chronic kidney and cardiometabolic diseases, announced today that two thought leaders, George L. Bakris, M.D. and Gordon H. Williams, M.D., have been appointed to InVasc’s Scientific Advisory Board (SAB). These distinguished clinician-scientists will provide guidance to InVasc as it advances its portfolio of products through preclinical and clinical development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES